Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Activity Description

In this CE Concepts Grand Rounds series, expert faculty will discuss strategies to better integrate diagnostic and prognostic biomarkers for DLBCL, utilize an evidence-based approach for personalizing treatment for patients with R/R DLBCL, and identify and mitigate the impact of AEs associated with novel therapies used in the treatment of patients with R/R DLBCL.

Target Audience

Academic and community-based hematologist/oncologists, nurses, nurse practitioners (NPs), and physician associates (PAs), and pharmacists specializing in oncology

Learning Objectives

At the conclusion of this activity, learners will be able to better:

• Integrate diagnostic and prognostic biomarkers for DLBCL in order to develop personalized treatment strategies for patients
• Utilize an evidence-based approach for personalizing treatment for patients with R/R DLBCL, taking into consideration efficacy, safety, and patient-specific factors to optimize patient outcomes
• Develop strategies to identify and mitigate the impact of AEs associated with novel therapies used in the treatment of patients with R/R DLBCL

Credit Information

Jointly Accredited Provider
In support of improving patient care, Creative Educational Concepts, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)
Creative Educational Concepts, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC)
This activity is designated for 1.0 contact hours.

Oncology Nursing Certification (ONCC)
This activity is designated for 1.0 contact hours. The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

Pharmacists (ACPE)
This application-based activity is approved for 1.0 contact hours (0.1 CEUs) of continuing pharmacy credit (JA0007101-0000-24-019-L01-P).

RCP Canada
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.